UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies

Current Alzheimer research, 2010-02, Vol.7 (1), p.67-73

2010

Volltextzugriff (PDF)

Safety of lumbar puncture procedures in patients with Alzheimer's disease

Current Alzheimer research, 2009-06, Vol.6 (3), p.290-292

2009

Volltextzugriff (PDF)

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly

Journal of Alzheimer's disease, 2017-01, Vol.56 (2), p.687-697

2017

Volltextzugriff (PDF)

Long‐lasting acetylcholinesterase splice variations in anticholinesterase‐treated Alzheimer's disease patients

Journal of neurochemistry, 2004-03, Vol.88 (5), p.1102-1113

2004

Volltextzugriff (PDF)

Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates

Journal of Alzheimer's disease, 2017-01, Vol.55 (3), p.1285-1294

2017

Volltextzugriff (PDF)

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ε4 allele, in relation to cognitive function and cerebral glucose metabolism

Neurobiology of disease, 2006-11, Vol.24 (2), p.326-333

2006

Volltextzugriff (PDF)

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

Neurology, 2002-08, Vol.59 (4), p.563-572

2002

Volltextzugriff (PDF)

Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients

European journal of neurology, 2004-04, Vol.11 (4), p.253-261

2004

Volltextzugriff (PDF)

Characterization of the Human FLICE‐Inhibitory Protein Locus and Comparison of the Anti‐Apoptotic Activity of Four Different FLIP Isoforms

Scandinavian journal of immunology, 2001-07, Vol.54 (1‐2), p.180-189

2001

Volltextzugriff (PDF)

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

Neurobiology of aging, 2008-08, Vol.29 (8), p.1204-1217

2008

Volltextzugriff (PDF)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders

International journal of alzheimer's disease, 2012, Vol.2012 (2012), p.1-9

2012

Volltextzugriff (PDF)

DMSO: A Mixed-Competitive Inhibitor of Human Acetylcholinesterase

ACS chemical neuroscience, 2017-12, Vol.8 (12), p.2618-2625

2017

Volltextzugriff (PDF)

Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme—A plausible missing link for their association with incidence of dementia

Alzheimer's & dementia, 2020-07, Vol.16 (7), p.1031-1042

2020

Volltextzugriff (PDF)

Allosteric Binding Sites of Aβ Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico Molecular Modeling

International journal of molecular sciences, 2022-05, Vol.23 (11), p.6073

2022

Volltextzugriff (PDF)

Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs

Brain (London, England : 1878), 2016-01, Vol.139 (Pt 1), p.174-192

2016

Volltextzugriff (PDF)

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment

JOURNAL OF NEURAL TRANSMISSION, 2006-11, Vol.113 (11), p.1791-1801

2006

Volltextzugriff (PDF)

A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease

Primary care companion for CNS disorders, 2013, Vol.15 (2)

2013

Volltextzugriff (PDF)

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening

Scientific reports, 2017-11, Vol.7 (1), p.16287-17, Article 16287

2017

Volltextzugriff (PDF)

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

Dementia and geriatric cognitive disorders, 2010-01, Vol.29 (3), p.204-212

2010

Volltextzugriff (PDF)

New ligands of choline acetyltransferase as therapeutics and in vivo functional biomarkers in Alzheimer’s disease

NEUROBIOLOGY OF AGING, 2016-03, Vol.39, p.S29-S29

Darreh-Shori, Taher

2016

Volltextzugriff (PDF)

Presence of key cholinergic enzymes in human spermatozoa and seminal fluid

Biology of reproduction, 2024-01, Vol.110 (1), p.63-77

2024

Volltextzugriff (PDF)

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

Frontiers in aging neuroscience, 2021-08, Vol.13, p.704583-704583

2021

Volltextzugriff (PDF)

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization

Scientific reports, 2016-08, Vol.6 (1), p.31247-31247, Article 31247

2016

Volltextzugriff (PDF)

Esomeprazole reduces sperm motility index by targeting the spermic cholinergic machinery: A mechanistic study for the association between use of proton pump inhibitors and reduced sperm motility index

Biochemical pharmacology, 2020-12, Vol.182, p.114212, Article 114212

2020

Volltextzugriff (PDF)

Changes in neuromuscular structure and functions of human colon during ageing are region-dependent

Gut, 2019-07, Vol.68 (7), p.1210-1223

2019

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(127)
Tagungsberichte
(6)

Sprache

Englisch
(133)

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(70)
Science & Technology
(56)
Life Sciences & Biomedicine
(50)
Humans
(46)
Alzheimer's Disease
(45)
Neurosciences & Neurology
(37)
Neurosciences
(35)
Male
(33)
Female
(29)
Neurology
(27)
Aged
(25)
Acetylcholinesterase
(23)
Cerebrospinal Fluid
(21)
Alzheimer Disease - Drug Therapy
(18)
Alzheimer’s Disease
(18)
Clinical Neurology
(17)
Alzheimer Disease - Cerebrospinal Fluid
(16)
Butyrylcholinesterase
(15)
Middle Aged
(15)
Dementia
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies

Safety of lumbar puncture procedures in patients with Alzheimer's disease

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly

Long‐lasting acetylcholinesterase splice variations in anticholinesterase‐treated Alzheimer's disease patients

Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ε4 allele, in relation to cognitive function and cerebral glucose metabolism

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients

Characterization of the Human FLICE‐Inhibitory Protein Locus and Comparison of the Anti‐Apoptotic Activity of Four Different FLIP Isoforms

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders

DMSO: A Mixed-Competitive Inhibitor of Human Acetylcholinesterase

Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme—A plausible missing link for their association with incidence of dementia

Allosteric Binding Sites of Aβ Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico Molecular Modeling

Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment

A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

New ligands of choline acetyltransferase as therapeutics and in vivo functional biomarkers in Alzheimer’s disease

Presence of key cholinergic enzymes in human spermatozoa and seminal fluid

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization

Esomeprazole reduces sperm motility index by targeting the spermic cholinergic machinery: A mechanistic study for the association between use of proton pump inhibitors and reduced sperm motility index

Changes in neuromuscular structure and functions of human colon during ageing are region-dependent

Suchergebnisse filtern